Global Pet NSAIDs Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Pet Non-steroidal anti-inflammatory drugs (NSAIDs) are medicines that are widely used to relieve pain, reduce inflammation, and bring down a high temperature. They can relieve the pain caused by inflammation of the pet's knee joint.
LPI (LP Information)' newest research report, the “Pet NSAIDs Industry Forecast” looks at past sales and reviews total world Pet NSAIDs sales in 2022, providing a comprehensive analysis by region and market sector of projected Pet NSAIDs sales for 2023 through 2029. With Pet NSAIDs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet NSAIDs industry.
This Insight Report provides a comprehensive analysis of the global Pet NSAIDs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pet NSAIDs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pet NSAIDs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet NSAIDs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet NSAIDs.
The global Pet NSAIDs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pet NSAIDs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pet NSAIDs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pet NSAIDs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pet NSAIDs players cover Zoetis, Elanco, PREVICOX, Metacam, Chanelle Pharma, AVENTIX, Woodruff, KRKA UK Ltd and Dechra, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet NSAIDs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Pet NSAIDs market?
What factors are driving Pet NSAIDs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pet NSAIDs market opportunities vary by end market size?
How does Pet NSAIDs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Pet Non-steroidal anti-inflammatory drugs (NSAIDs) are medicines that are widely used to relieve pain, reduce inflammation, and bring down a high temperature. They can relieve the pain caused by inflammation of the pet's knee joint.
LPI (LP Information)' newest research report, the “Pet NSAIDs Industry Forecast” looks at past sales and reviews total world Pet NSAIDs sales in 2022, providing a comprehensive analysis by region and market sector of projected Pet NSAIDs sales for 2023 through 2029. With Pet NSAIDs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet NSAIDs industry.
This Insight Report provides a comprehensive analysis of the global Pet NSAIDs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pet NSAIDs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pet NSAIDs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet NSAIDs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet NSAIDs.
The global Pet NSAIDs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pet NSAIDs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pet NSAIDs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pet NSAIDs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pet NSAIDs players cover Zoetis, Elanco, PREVICOX, Metacam, Chanelle Pharma, AVENTIX, Woodruff, KRKA UK Ltd and Dechra, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet NSAIDs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Carprofen
- Deracoxib
- Firocoxib
- Meloxicam
- Dog
- Cat
- Horse
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Zoetis
- Elanco
- PREVICOX
- Metacam
- Chanelle Pharma
- AVENTIX
- Woodruff
- KRKA UK Ltd
- Dechra
- Parnell
- VetUK
- Norbrook
- Alivira Animal Health
- Vedco Inc
- Vethical
- Vetoquinol
- Pivetal
What is the 10-year outlook for the global Pet NSAIDs market?
What factors are driving Pet NSAIDs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pet NSAIDs market opportunities vary by end market size?
How does Pet NSAIDs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pet NSAIDs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pet NSAIDs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pet NSAIDs by Country/Region, 2018, 2022 & 2029
2.2 Pet NSAIDs Segment by Type
2.2.1 Carprofen
2.2.2 Deracoxib
2.2.3 Firocoxib
2.2.4 Meloxicam
2.3 Pet NSAIDs Sales by Type
2.3.1 Global Pet NSAIDs Sales Market Share by Type (2018-2023)
2.3.2 Global Pet NSAIDs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pet NSAIDs Sale Price by Type (2018-2023)
2.4 Pet NSAIDs Segment by Application
2.4.1 Dog
2.4.2 Cat
2.4.3 Horse
2.4.4 Others
2.5 Pet NSAIDs Sales by Application
2.5.1 Global Pet NSAIDs Sale Market Share by Application (2018-2023)
2.5.2 Global Pet NSAIDs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pet NSAIDs Sale Price by Application (2018-2023)
3 GLOBAL PET NSAIDS BY COMPANY
3.1 Global Pet NSAIDs Breakdown Data by Company
3.1.1 Global Pet NSAIDs Annual Sales by Company (2018-2023)
3.1.2 Global Pet NSAIDs Sales Market Share by Company (2018-2023)
3.2 Global Pet NSAIDs Annual Revenue by Company (2018-2023)
3.2.1 Global Pet NSAIDs Revenue by Company (2018-2023)
3.2.2 Global Pet NSAIDs Revenue Market Share by Company (2018-2023)
3.3 Global Pet NSAIDs Sale Price by Company
3.4 Key Manufacturers Pet NSAIDs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet NSAIDs Product Location Distribution
3.4.2 Players Pet NSAIDs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PET NSAIDS BY GEOGRAPHIC REGION
4.1 World Historic Pet NSAIDs Market Size by Geographic Region (2018-2023)
4.1.1 Global Pet NSAIDs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pet NSAIDs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pet NSAIDs Market Size by Country/Region (2018-2023)
4.2.1 Global Pet NSAIDs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pet NSAIDs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pet NSAIDs Sales Growth
4.4 APAC Pet NSAIDs Sales Growth
4.5 Europe Pet NSAIDs Sales Growth
4.6 Middle East & Africa Pet NSAIDs Sales Growth
5 AMERICAS
5.1 Americas Pet NSAIDs Sales by Country
5.1.1 Americas Pet NSAIDs Sales by Country (2018-2023)
5.1.2 Americas Pet NSAIDs Revenue by Country (2018-2023)
5.2 Americas Pet NSAIDs Sales by Type
5.3 Americas Pet NSAIDs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet NSAIDs Sales by Region
6.1.1 APAC Pet NSAIDs Sales by Region (2018-2023)
6.1.2 APAC Pet NSAIDs Revenue by Region (2018-2023)
6.2 APAC Pet NSAIDs Sales by Type
6.3 APAC Pet NSAIDs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pet NSAIDs by Country
7.1.1 Europe Pet NSAIDs Sales by Country (2018-2023)
7.1.2 Europe Pet NSAIDs Revenue by Country (2018-2023)
7.2 Europe Pet NSAIDs Sales by Type
7.3 Europe Pet NSAIDs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pet NSAIDs by Country
8.1.1 Middle East & Africa Pet NSAIDs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pet NSAIDs Revenue by Country (2018-2023)
8.2 Middle East & Africa Pet NSAIDs Sales by Type
8.3 Middle East & Africa Pet NSAIDs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet NSAIDs
10.3 Manufacturing Process Analysis of Pet NSAIDs
10.4 Industry Chain Structure of Pet NSAIDs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet NSAIDs Distributors
11.3 Pet NSAIDs Customer
12 WORLD FORECAST REVIEW FOR PET NSAIDS BY GEOGRAPHIC REGION
12.1 Global Pet NSAIDs Market Size Forecast by Region
12.1.1 Global Pet NSAIDs Forecast by Region (2024-2029)
12.1.2 Global Pet NSAIDs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pet NSAIDs Forecast by Type
12.7 Global Pet NSAIDs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Pet NSAIDs Product Portfolios and Specifications
13.1.3 Zoetis Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Elanco
13.2.1 Elanco Company Information
13.2.2 Elanco Pet NSAIDs Product Portfolios and Specifications
13.2.3 Elanco Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Elanco Main Business Overview
13.2.5 Elanco Latest Developments
13.3 PREVICOX
13.3.1 PREVICOX Company Information
13.3.2 PREVICOX Pet NSAIDs Product Portfolios and Specifications
13.3.3 PREVICOX Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 PREVICOX Main Business Overview
13.3.5 PREVICOX Latest Developments
13.4 Metacam
13.4.1 Metacam Company Information
13.4.2 Metacam Pet NSAIDs Product Portfolios and Specifications
13.4.3 Metacam Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Metacam Main Business Overview
13.4.5 Metacam Latest Developments
13.5 Chanelle Pharma
13.5.1 Chanelle Pharma Company Information
13.5.2 Chanelle Pharma Pet NSAIDs Product Portfolios and Specifications
13.5.3 Chanelle Pharma Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Chanelle Pharma Main Business Overview
13.5.5 Chanelle Pharma Latest Developments
13.6 AVENTIX
13.6.1 AVENTIX Company Information
13.6.2 AVENTIX Pet NSAIDs Product Portfolios and Specifications
13.6.3 AVENTIX Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 AVENTIX Main Business Overview
13.6.5 AVENTIX Latest Developments
13.7 Woodruff
13.7.1 Woodruff Company Information
13.7.2 Woodruff Pet NSAIDs Product Portfolios and Specifications
13.7.3 Woodruff Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Woodruff Main Business Overview
13.7.5 Woodruff Latest Developments
13.8 KRKA UK Ltd
13.8.1 KRKA UK Ltd Company Information
13.8.2 KRKA UK Ltd Pet NSAIDs Product Portfolios and Specifications
13.8.3 KRKA UK Ltd Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 KRKA UK Ltd Main Business Overview
13.8.5 KRKA UK Ltd Latest Developments
13.9 Dechra
13.9.1 Dechra Company Information
13.9.2 Dechra Pet NSAIDs Product Portfolios and Specifications
13.9.3 Dechra Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Dechra Main Business Overview
13.9.5 Dechra Latest Developments
13.10 Parnell
13.10.1 Parnell Company Information
13.10.2 Parnell Pet NSAIDs Product Portfolios and Specifications
13.10.3 Parnell Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Parnell Main Business Overview
13.10.5 Parnell Latest Developments
13.11 VetUK
13.11.1 VetUK Company Information
13.11.2 VetUK Pet NSAIDs Product Portfolios and Specifications
13.11.3 VetUK Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 VetUK Main Business Overview
13.11.5 VetUK Latest Developments
13.12 Norbrook
13.12.1 Norbrook Company Information
13.12.2 Norbrook Pet NSAIDs Product Portfolios and Specifications
13.12.3 Norbrook Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Norbrook Main Business Overview
13.12.5 Norbrook Latest Developments
13.13 Alivira Animal Health
13.13.1 Alivira Animal Health Company Information
13.13.2 Alivira Animal Health Pet NSAIDs Product Portfolios and Specifications
13.13.3 Alivira Animal Health Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Alivira Animal Health Main Business Overview
13.13.5 Alivira Animal Health Latest Developments
13.14 Vedco Inc
13.14.1 Vedco Inc Company Information
13.14.2 Vedco Inc Pet NSAIDs Product Portfolios and Specifications
13.14.3 Vedco Inc Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Vedco Inc Main Business Overview
13.14.5 Vedco Inc Latest Developments
13.15 Vethical
13.15.1 Vethical Company Information
13.15.2 Vethical Pet NSAIDs Product Portfolios and Specifications
13.15.3 Vethical Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Vethical Main Business Overview
13.15.5 Vethical Latest Developments
13.16 Vetoquinol
13.16.1 Vetoquinol Company Information
13.16.2 Vetoquinol Pet NSAIDs Product Portfolios and Specifications
13.16.3 Vetoquinol Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Vetoquinol Main Business Overview
13.16.5 Vetoquinol Latest Developments
13.17 Pivetal
13.17.1 Pivetal Company Information
13.17.2 Pivetal Pet NSAIDs Product Portfolios and Specifications
13.17.3 Pivetal Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Pivetal Main Business Overview
13.17.5 Pivetal Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pet NSAIDs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pet NSAIDs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pet NSAIDs by Country/Region, 2018, 2022 & 2029
2.2 Pet NSAIDs Segment by Type
2.2.1 Carprofen
2.2.2 Deracoxib
2.2.3 Firocoxib
2.2.4 Meloxicam
2.3 Pet NSAIDs Sales by Type
2.3.1 Global Pet NSAIDs Sales Market Share by Type (2018-2023)
2.3.2 Global Pet NSAIDs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pet NSAIDs Sale Price by Type (2018-2023)
2.4 Pet NSAIDs Segment by Application
2.4.1 Dog
2.4.2 Cat
2.4.3 Horse
2.4.4 Others
2.5 Pet NSAIDs Sales by Application
2.5.1 Global Pet NSAIDs Sale Market Share by Application (2018-2023)
2.5.2 Global Pet NSAIDs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pet NSAIDs Sale Price by Application (2018-2023)
3 GLOBAL PET NSAIDS BY COMPANY
3.1 Global Pet NSAIDs Breakdown Data by Company
3.1.1 Global Pet NSAIDs Annual Sales by Company (2018-2023)
3.1.2 Global Pet NSAIDs Sales Market Share by Company (2018-2023)
3.2 Global Pet NSAIDs Annual Revenue by Company (2018-2023)
3.2.1 Global Pet NSAIDs Revenue by Company (2018-2023)
3.2.2 Global Pet NSAIDs Revenue Market Share by Company (2018-2023)
3.3 Global Pet NSAIDs Sale Price by Company
3.4 Key Manufacturers Pet NSAIDs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet NSAIDs Product Location Distribution
3.4.2 Players Pet NSAIDs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PET NSAIDS BY GEOGRAPHIC REGION
4.1 World Historic Pet NSAIDs Market Size by Geographic Region (2018-2023)
4.1.1 Global Pet NSAIDs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pet NSAIDs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pet NSAIDs Market Size by Country/Region (2018-2023)
4.2.1 Global Pet NSAIDs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pet NSAIDs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pet NSAIDs Sales Growth
4.4 APAC Pet NSAIDs Sales Growth
4.5 Europe Pet NSAIDs Sales Growth
4.6 Middle East & Africa Pet NSAIDs Sales Growth
5 AMERICAS
5.1 Americas Pet NSAIDs Sales by Country
5.1.1 Americas Pet NSAIDs Sales by Country (2018-2023)
5.1.2 Americas Pet NSAIDs Revenue by Country (2018-2023)
5.2 Americas Pet NSAIDs Sales by Type
5.3 Americas Pet NSAIDs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet NSAIDs Sales by Region
6.1.1 APAC Pet NSAIDs Sales by Region (2018-2023)
6.1.2 APAC Pet NSAIDs Revenue by Region (2018-2023)
6.2 APAC Pet NSAIDs Sales by Type
6.3 APAC Pet NSAIDs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pet NSAIDs by Country
7.1.1 Europe Pet NSAIDs Sales by Country (2018-2023)
7.1.2 Europe Pet NSAIDs Revenue by Country (2018-2023)
7.2 Europe Pet NSAIDs Sales by Type
7.3 Europe Pet NSAIDs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pet NSAIDs by Country
8.1.1 Middle East & Africa Pet NSAIDs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pet NSAIDs Revenue by Country (2018-2023)
8.2 Middle East & Africa Pet NSAIDs Sales by Type
8.3 Middle East & Africa Pet NSAIDs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet NSAIDs
10.3 Manufacturing Process Analysis of Pet NSAIDs
10.4 Industry Chain Structure of Pet NSAIDs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet NSAIDs Distributors
11.3 Pet NSAIDs Customer
12 WORLD FORECAST REVIEW FOR PET NSAIDS BY GEOGRAPHIC REGION
12.1 Global Pet NSAIDs Market Size Forecast by Region
12.1.1 Global Pet NSAIDs Forecast by Region (2024-2029)
12.1.2 Global Pet NSAIDs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pet NSAIDs Forecast by Type
12.7 Global Pet NSAIDs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Pet NSAIDs Product Portfolios and Specifications
13.1.3 Zoetis Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Elanco
13.2.1 Elanco Company Information
13.2.2 Elanco Pet NSAIDs Product Portfolios and Specifications
13.2.3 Elanco Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Elanco Main Business Overview
13.2.5 Elanco Latest Developments
13.3 PREVICOX
13.3.1 PREVICOX Company Information
13.3.2 PREVICOX Pet NSAIDs Product Portfolios and Specifications
13.3.3 PREVICOX Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 PREVICOX Main Business Overview
13.3.5 PREVICOX Latest Developments
13.4 Metacam
13.4.1 Metacam Company Information
13.4.2 Metacam Pet NSAIDs Product Portfolios and Specifications
13.4.3 Metacam Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Metacam Main Business Overview
13.4.5 Metacam Latest Developments
13.5 Chanelle Pharma
13.5.1 Chanelle Pharma Company Information
13.5.2 Chanelle Pharma Pet NSAIDs Product Portfolios and Specifications
13.5.3 Chanelle Pharma Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Chanelle Pharma Main Business Overview
13.5.5 Chanelle Pharma Latest Developments
13.6 AVENTIX
13.6.1 AVENTIX Company Information
13.6.2 AVENTIX Pet NSAIDs Product Portfolios and Specifications
13.6.3 AVENTIX Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 AVENTIX Main Business Overview
13.6.5 AVENTIX Latest Developments
13.7 Woodruff
13.7.1 Woodruff Company Information
13.7.2 Woodruff Pet NSAIDs Product Portfolios and Specifications
13.7.3 Woodruff Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Woodruff Main Business Overview
13.7.5 Woodruff Latest Developments
13.8 KRKA UK Ltd
13.8.1 KRKA UK Ltd Company Information
13.8.2 KRKA UK Ltd Pet NSAIDs Product Portfolios and Specifications
13.8.3 KRKA UK Ltd Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 KRKA UK Ltd Main Business Overview
13.8.5 KRKA UK Ltd Latest Developments
13.9 Dechra
13.9.1 Dechra Company Information
13.9.2 Dechra Pet NSAIDs Product Portfolios and Specifications
13.9.3 Dechra Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Dechra Main Business Overview
13.9.5 Dechra Latest Developments
13.10 Parnell
13.10.1 Parnell Company Information
13.10.2 Parnell Pet NSAIDs Product Portfolios and Specifications
13.10.3 Parnell Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Parnell Main Business Overview
13.10.5 Parnell Latest Developments
13.11 VetUK
13.11.1 VetUK Company Information
13.11.2 VetUK Pet NSAIDs Product Portfolios and Specifications
13.11.3 VetUK Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 VetUK Main Business Overview
13.11.5 VetUK Latest Developments
13.12 Norbrook
13.12.1 Norbrook Company Information
13.12.2 Norbrook Pet NSAIDs Product Portfolios and Specifications
13.12.3 Norbrook Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Norbrook Main Business Overview
13.12.5 Norbrook Latest Developments
13.13 Alivira Animal Health
13.13.1 Alivira Animal Health Company Information
13.13.2 Alivira Animal Health Pet NSAIDs Product Portfolios and Specifications
13.13.3 Alivira Animal Health Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Alivira Animal Health Main Business Overview
13.13.5 Alivira Animal Health Latest Developments
13.14 Vedco Inc
13.14.1 Vedco Inc Company Information
13.14.2 Vedco Inc Pet NSAIDs Product Portfolios and Specifications
13.14.3 Vedco Inc Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Vedco Inc Main Business Overview
13.14.5 Vedco Inc Latest Developments
13.15 Vethical
13.15.1 Vethical Company Information
13.15.2 Vethical Pet NSAIDs Product Portfolios and Specifications
13.15.3 Vethical Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Vethical Main Business Overview
13.15.5 Vethical Latest Developments
13.16 Vetoquinol
13.16.1 Vetoquinol Company Information
13.16.2 Vetoquinol Pet NSAIDs Product Portfolios and Specifications
13.16.3 Vetoquinol Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Vetoquinol Main Business Overview
13.16.5 Vetoquinol Latest Developments
13.17 Pivetal
13.17.1 Pivetal Company Information
13.17.2 Pivetal Pet NSAIDs Product Portfolios and Specifications
13.17.3 Pivetal Pet NSAIDs Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Pivetal Main Business Overview
13.17.5 Pivetal Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pet NSAIDs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pet NSAIDs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Carprofen
Table 4. Major Players of Deracoxib
Table 5. Major Players of Firocoxib
Table 6. Major Players of Meloxicam
Table 7. Global Pet NSAIDs Sales by Type (2018-2023) & (K Units)
Table 8. Global Pet NSAIDs Sales Market Share by Type (2018-2023)
Table 9. Global Pet NSAIDs Revenue by Type (2018-2023) & ($ million)
Table 10. Global Pet NSAIDs Revenue Market Share by Type (2018-2023)
Table 11. Global Pet NSAIDs Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Pet NSAIDs Sales by Application (2018-2023) & (K Units)
Table 13. Global Pet NSAIDs Sales Market Share by Application (2018-2023)
Table 14. Global Pet NSAIDs Revenue by Application (2018-2023)
Table 15. Global Pet NSAIDs Revenue Market Share by Application (2018-2023)
Table 16. Global Pet NSAIDs Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Pet NSAIDs Sales by Company (2018-2023) & (K Units)
Table 18. Global Pet NSAIDs Sales Market Share by Company (2018-2023)
Table 19. Global Pet NSAIDs Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Pet NSAIDs Revenue Market Share by Company (2018-2023)
Table 21. Global Pet NSAIDs Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Pet NSAIDs Producing Area Distribution and Sales Area
Table 23. Players Pet NSAIDs Products Offered
Table 24. Pet NSAIDs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Pet NSAIDs Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Pet NSAIDs Sales Market Share Geographic Region (2018-2023)
Table 29. Global Pet NSAIDs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Pet NSAIDs Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Pet NSAIDs Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Pet NSAIDs Sales Market Share by Country/Region (2018-2023)
Table 33. Global Pet NSAIDs Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Pet NSAIDs Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Pet NSAIDs Sales by Country (2018-2023) & (K Units)
Table 36. Americas Pet NSAIDs Sales Market Share by Country (2018-2023)
Table 37. Americas Pet NSAIDs Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Pet NSAIDs Revenue Market Share by Country (2018-2023)
Table 39. Americas Pet NSAIDs Sales by Type (2018-2023) & (K Units)
Table 40. Americas Pet NSAIDs Sales by Application (2018-2023) & (K Units)
Table 41. APAC Pet NSAIDs Sales by Region (2018-2023) & (K Units)
Table 42. APAC Pet NSAIDs Sales Market Share by Region (2018-2023)
Table 43. APAC Pet NSAIDs Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Pet NSAIDs Revenue Market Share by Region (2018-2023)
Table 45. APAC Pet NSAIDs Sales by Type (2018-2023) & (K Units)
Table 46. APAC Pet NSAIDs Sales by Application (2018-2023) & (K Units)
Table 47. Europe Pet NSAIDs Sales by Country (2018-2023) & (K Units)
Table 48. Europe Pet NSAIDs Sales Market Share by Country (2018-2023)
Table 49. Europe Pet NSAIDs Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Pet NSAIDs Revenue Market Share by Country (2018-2023)
Table 51. Europe Pet NSAIDs Sales by Type (2018-2023) & (K Units)
Table 52. Europe Pet NSAIDs Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Pet NSAIDs Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Pet NSAIDs Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Pet NSAIDs Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Pet NSAIDs Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Pet NSAIDs Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Pet NSAIDs Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Pet NSAIDs
Table 60. Key Market Challenges & Risks of Pet NSAIDs
Table 61. Key Industry Trends of Pet NSAIDs
Table 62. Pet NSAIDs Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Pet NSAIDs Distributors List
Table 65. Pet NSAIDs Customer List
Table 66. Global Pet NSAIDs Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Pet NSAIDs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Pet NSAIDs Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Pet NSAIDs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Pet NSAIDs Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Pet NSAIDs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Pet NSAIDs Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Pet NSAIDs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Pet NSAIDs Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Pet NSAIDs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Pet NSAIDs Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Pet NSAIDs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Pet NSAIDs Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Pet NSAIDs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Zoetis Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 81. Zoetis Pet NSAIDs Product Portfolios and Specifications
Table 82. Zoetis Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Zoetis Main Business
Table 84. Zoetis Latest Developments
Table 85. Elanco Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 86. Elanco Pet NSAIDs Product Portfolios and Specifications
Table 87. Elanco Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Elanco Main Business
Table 89. Elanco Latest Developments
Table 90. PREVICOX Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 91. PREVICOX Pet NSAIDs Product Portfolios and Specifications
Table 92. PREVICOX Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. PREVICOX Main Business
Table 94. PREVICOX Latest Developments
Table 95. Metacam Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 96. Metacam Pet NSAIDs Product Portfolios and Specifications
Table 97. Metacam Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Metacam Main Business
Table 99. Metacam Latest Developments
Table 100. Chanelle Pharma Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 101. Chanelle Pharma Pet NSAIDs Product Portfolios and Specifications
Table 102. Chanelle Pharma Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Chanelle Pharma Main Business
Table 104. Chanelle Pharma Latest Developments
Table 105. AVENTIX Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 106. AVENTIX Pet NSAIDs Product Portfolios and Specifications
Table 107. AVENTIX Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. AVENTIX Main Business
Table 109. AVENTIX Latest Developments
Table 110. Woodruff Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 111. Woodruff Pet NSAIDs Product Portfolios and Specifications
Table 112. Woodruff Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Woodruff Main Business
Table 114. Woodruff Latest Developments
Table 115. KRKA UK Ltd Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 116. KRKA UK Ltd Pet NSAIDs Product Portfolios and Specifications
Table 117. KRKA UK Ltd Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. KRKA UK Ltd Main Business
Table 119. KRKA UK Ltd Latest Developments
Table 120. Dechra Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 121. Dechra Pet NSAIDs Product Portfolios and Specifications
Table 122. Dechra Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Dechra Main Business
Table 124. Dechra Latest Developments
Table 125. Parnell Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 126. Parnell Pet NSAIDs Product Portfolios and Specifications
Table 127. Parnell Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Parnell Main Business
Table 129. Parnell Latest Developments
Table 130. VetUK Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 131. VetUK Pet NSAIDs Product Portfolios and Specifications
Table 132. VetUK Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. VetUK Main Business
Table 134. VetUK Latest Developments
Table 135. Norbrook Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 136. Norbrook Pet NSAIDs Product Portfolios and Specifications
Table 137. Norbrook Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Norbrook Main Business
Table 139. Norbrook Latest Developments
Table 140. Alivira Animal Health Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 141. Alivira Animal Health Pet NSAIDs Product Portfolios and Specifications
Table 142. Alivira Animal Health Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Alivira Animal Health Main Business
Table 144. Alivira Animal Health Latest Developments
Table 145. Vedco Inc Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 146. Vedco Inc Pet NSAIDs Product Portfolios and Specifications
Table 147. Vedco Inc Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Vedco Inc Main Business
Table 149. Vedco Inc Latest Developments
Table 150. Vethical Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 151. Vethical Pet NSAIDs Product Portfolios and Specifications
Table 152. Vethical Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Vethical Main Business
Table 154. Vethical Latest Developments
Table 155. Vetoquinol Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 156. Vetoquinol Pet NSAIDs Product Portfolios and Specifications
Table 157. Vetoquinol Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Vetoquinol Main Business
Table 159. Vetoquinol Latest Developments
Table 160. Pivetal Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 161. Pivetal Pet NSAIDs Product Portfolios and Specifications
Table 162. Pivetal Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Pivetal Main Business
Table 164. Pivetal Latest Developments
Table 1. Pet NSAIDs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pet NSAIDs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Carprofen
Table 4. Major Players of Deracoxib
Table 5. Major Players of Firocoxib
Table 6. Major Players of Meloxicam
Table 7. Global Pet NSAIDs Sales by Type (2018-2023) & (K Units)
Table 8. Global Pet NSAIDs Sales Market Share by Type (2018-2023)
Table 9. Global Pet NSAIDs Revenue by Type (2018-2023) & ($ million)
Table 10. Global Pet NSAIDs Revenue Market Share by Type (2018-2023)
Table 11. Global Pet NSAIDs Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Pet NSAIDs Sales by Application (2018-2023) & (K Units)
Table 13. Global Pet NSAIDs Sales Market Share by Application (2018-2023)
Table 14. Global Pet NSAIDs Revenue by Application (2018-2023)
Table 15. Global Pet NSAIDs Revenue Market Share by Application (2018-2023)
Table 16. Global Pet NSAIDs Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Pet NSAIDs Sales by Company (2018-2023) & (K Units)
Table 18. Global Pet NSAIDs Sales Market Share by Company (2018-2023)
Table 19. Global Pet NSAIDs Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Pet NSAIDs Revenue Market Share by Company (2018-2023)
Table 21. Global Pet NSAIDs Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Pet NSAIDs Producing Area Distribution and Sales Area
Table 23. Players Pet NSAIDs Products Offered
Table 24. Pet NSAIDs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Pet NSAIDs Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Pet NSAIDs Sales Market Share Geographic Region (2018-2023)
Table 29. Global Pet NSAIDs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Pet NSAIDs Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Pet NSAIDs Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Pet NSAIDs Sales Market Share by Country/Region (2018-2023)
Table 33. Global Pet NSAIDs Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Pet NSAIDs Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Pet NSAIDs Sales by Country (2018-2023) & (K Units)
Table 36. Americas Pet NSAIDs Sales Market Share by Country (2018-2023)
Table 37. Americas Pet NSAIDs Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Pet NSAIDs Revenue Market Share by Country (2018-2023)
Table 39. Americas Pet NSAIDs Sales by Type (2018-2023) & (K Units)
Table 40. Americas Pet NSAIDs Sales by Application (2018-2023) & (K Units)
Table 41. APAC Pet NSAIDs Sales by Region (2018-2023) & (K Units)
Table 42. APAC Pet NSAIDs Sales Market Share by Region (2018-2023)
Table 43. APAC Pet NSAIDs Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Pet NSAIDs Revenue Market Share by Region (2018-2023)
Table 45. APAC Pet NSAIDs Sales by Type (2018-2023) & (K Units)
Table 46. APAC Pet NSAIDs Sales by Application (2018-2023) & (K Units)
Table 47. Europe Pet NSAIDs Sales by Country (2018-2023) & (K Units)
Table 48. Europe Pet NSAIDs Sales Market Share by Country (2018-2023)
Table 49. Europe Pet NSAIDs Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Pet NSAIDs Revenue Market Share by Country (2018-2023)
Table 51. Europe Pet NSAIDs Sales by Type (2018-2023) & (K Units)
Table 52. Europe Pet NSAIDs Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Pet NSAIDs Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Pet NSAIDs Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Pet NSAIDs Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Pet NSAIDs Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Pet NSAIDs Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Pet NSAIDs Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Pet NSAIDs
Table 60. Key Market Challenges & Risks of Pet NSAIDs
Table 61. Key Industry Trends of Pet NSAIDs
Table 62. Pet NSAIDs Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Pet NSAIDs Distributors List
Table 65. Pet NSAIDs Customer List
Table 66. Global Pet NSAIDs Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Pet NSAIDs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Pet NSAIDs Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Pet NSAIDs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Pet NSAIDs Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Pet NSAIDs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Pet NSAIDs Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Pet NSAIDs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Pet NSAIDs Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Pet NSAIDs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Pet NSAIDs Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Pet NSAIDs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Pet NSAIDs Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Pet NSAIDs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Zoetis Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 81. Zoetis Pet NSAIDs Product Portfolios and Specifications
Table 82. Zoetis Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Zoetis Main Business
Table 84. Zoetis Latest Developments
Table 85. Elanco Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 86. Elanco Pet NSAIDs Product Portfolios and Specifications
Table 87. Elanco Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Elanco Main Business
Table 89. Elanco Latest Developments
Table 90. PREVICOX Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 91. PREVICOX Pet NSAIDs Product Portfolios and Specifications
Table 92. PREVICOX Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. PREVICOX Main Business
Table 94. PREVICOX Latest Developments
Table 95. Metacam Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 96. Metacam Pet NSAIDs Product Portfolios and Specifications
Table 97. Metacam Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Metacam Main Business
Table 99. Metacam Latest Developments
Table 100. Chanelle Pharma Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 101. Chanelle Pharma Pet NSAIDs Product Portfolios and Specifications
Table 102. Chanelle Pharma Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Chanelle Pharma Main Business
Table 104. Chanelle Pharma Latest Developments
Table 105. AVENTIX Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 106. AVENTIX Pet NSAIDs Product Portfolios and Specifications
Table 107. AVENTIX Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. AVENTIX Main Business
Table 109. AVENTIX Latest Developments
Table 110. Woodruff Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 111. Woodruff Pet NSAIDs Product Portfolios and Specifications
Table 112. Woodruff Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Woodruff Main Business
Table 114. Woodruff Latest Developments
Table 115. KRKA UK Ltd Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 116. KRKA UK Ltd Pet NSAIDs Product Portfolios and Specifications
Table 117. KRKA UK Ltd Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. KRKA UK Ltd Main Business
Table 119. KRKA UK Ltd Latest Developments
Table 120. Dechra Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 121. Dechra Pet NSAIDs Product Portfolios and Specifications
Table 122. Dechra Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Dechra Main Business
Table 124. Dechra Latest Developments
Table 125. Parnell Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 126. Parnell Pet NSAIDs Product Portfolios and Specifications
Table 127. Parnell Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Parnell Main Business
Table 129. Parnell Latest Developments
Table 130. VetUK Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 131. VetUK Pet NSAIDs Product Portfolios and Specifications
Table 132. VetUK Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. VetUK Main Business
Table 134. VetUK Latest Developments
Table 135. Norbrook Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 136. Norbrook Pet NSAIDs Product Portfolios and Specifications
Table 137. Norbrook Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Norbrook Main Business
Table 139. Norbrook Latest Developments
Table 140. Alivira Animal Health Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 141. Alivira Animal Health Pet NSAIDs Product Portfolios and Specifications
Table 142. Alivira Animal Health Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Alivira Animal Health Main Business
Table 144. Alivira Animal Health Latest Developments
Table 145. Vedco Inc Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 146. Vedco Inc Pet NSAIDs Product Portfolios and Specifications
Table 147. Vedco Inc Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Vedco Inc Main Business
Table 149. Vedco Inc Latest Developments
Table 150. Vethical Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 151. Vethical Pet NSAIDs Product Portfolios and Specifications
Table 152. Vethical Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Vethical Main Business
Table 154. Vethical Latest Developments
Table 155. Vetoquinol Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 156. Vetoquinol Pet NSAIDs Product Portfolios and Specifications
Table 157. Vetoquinol Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Vetoquinol Main Business
Table 159. Vetoquinol Latest Developments
Table 160. Pivetal Basic Information, Pet NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 161. Pivetal Pet NSAIDs Product Portfolios and Specifications
Table 162. Pivetal Pet NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Pivetal Main Business
Table 164. Pivetal Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pet NSAIDs
Figure 2. Pet NSAIDs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet NSAIDs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Pet NSAIDs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pet NSAIDs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Carprofen
Figure 10. Product Picture of Deracoxib
Figure 11. Product Picture of Firocoxib
Figure 12. Product Picture of Meloxicam
Figure 13. Global Pet NSAIDs Sales Market Share by Type in 2022
Figure 14. Global Pet NSAIDs Revenue Market Share by Type (2018-2023)
Figure 15. Pet NSAIDs Consumed in Dog
Figure 16. Global Pet NSAIDs Market: Dog (2018-2023) & (K Units)
Figure 17. Pet NSAIDs Consumed in Cat
Figure 18. Global Pet NSAIDs Market: Cat (2018-2023) & (K Units)
Figure 19. Pet NSAIDs Consumed in Horse
Figure 20. Global Pet NSAIDs Market: Horse (2018-2023) & (K Units)
Figure 21. Pet NSAIDs Consumed in Others
Figure 22. Global Pet NSAIDs Market: Others (2018-2023) & (K Units)
Figure 23. Global Pet NSAIDs Sales Market Share by Application (2022)
Figure 24. Global Pet NSAIDs Revenue Market Share by Application in 2022
Figure 25. Pet NSAIDs Sales Market by Company in 2022 (K Units)
Figure 26. Global Pet NSAIDs Sales Market Share by Company in 2022
Figure 27. Pet NSAIDs Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Pet NSAIDs Revenue Market Share by Company in 2022
Figure 29. Global Pet NSAIDs Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Pet NSAIDs Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Pet NSAIDs Sales 2018-2023 (K Units)
Figure 32. Americas Pet NSAIDs Revenue 2018-2023 ($ Millions)
Figure 33. APAC Pet NSAIDs Sales 2018-2023 (K Units)
Figure 34. APAC Pet NSAIDs Revenue 2018-2023 ($ Millions)
Figure 35. Europe Pet NSAIDs Sales 2018-2023 (K Units)
Figure 36. Europe Pet NSAIDs Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Pet NSAIDs Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Pet NSAIDs Revenue 2018-2023 ($ Millions)
Figure 39. Americas Pet NSAIDs Sales Market Share by Country in 2022
Figure 40. Americas Pet NSAIDs Revenue Market Share by Country in 2022
Figure 41. Americas Pet NSAIDs Sales Market Share by Type (2018-2023)
Figure 42. Americas Pet NSAIDs Sales Market Share by Application (2018-2023)
Figure 43. United States Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Pet NSAIDs Sales Market Share by Region in 2022
Figure 48. APAC Pet NSAIDs Revenue Market Share by Regions in 2022
Figure 49. APAC Pet NSAIDs Sales Market Share by Type (2018-2023)
Figure 50. APAC Pet NSAIDs Sales Market Share by Application (2018-2023)
Figure 51. China Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Pet NSAIDs Sales Market Share by Country in 2022
Figure 59. Europe Pet NSAIDs Revenue Market Share by Country in 2022
Figure 60. Europe Pet NSAIDs Sales Market Share by Type (2018-2023)
Figure 61. Europe Pet NSAIDs Sales Market Share by Application (2018-2023)
Figure 62. Germany Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Pet NSAIDs Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Pet NSAIDs Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Pet NSAIDs Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Pet NSAIDs Sales Market Share by Application (2018-2023)
Figure 71. Egypt Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Pet NSAIDs in 2022
Figure 77. Manufacturing Process Analysis of Pet NSAIDs
Figure 78. Industry Chain Structure of Pet NSAIDs
Figure 79. Channels of Distribution
Figure 80. Global Pet NSAIDs Sales Market Forecast by Region (2024-2029)
Figure 81. Global Pet NSAIDs Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Pet NSAIDs Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Pet NSAIDs Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Pet NSAIDs Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Pet NSAIDs Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Pet NSAIDs
Figure 2. Pet NSAIDs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet NSAIDs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Pet NSAIDs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pet NSAIDs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Carprofen
Figure 10. Product Picture of Deracoxib
Figure 11. Product Picture of Firocoxib
Figure 12. Product Picture of Meloxicam
Figure 13. Global Pet NSAIDs Sales Market Share by Type in 2022
Figure 14. Global Pet NSAIDs Revenue Market Share by Type (2018-2023)
Figure 15. Pet NSAIDs Consumed in Dog
Figure 16. Global Pet NSAIDs Market: Dog (2018-2023) & (K Units)
Figure 17. Pet NSAIDs Consumed in Cat
Figure 18. Global Pet NSAIDs Market: Cat (2018-2023) & (K Units)
Figure 19. Pet NSAIDs Consumed in Horse
Figure 20. Global Pet NSAIDs Market: Horse (2018-2023) & (K Units)
Figure 21. Pet NSAIDs Consumed in Others
Figure 22. Global Pet NSAIDs Market: Others (2018-2023) & (K Units)
Figure 23. Global Pet NSAIDs Sales Market Share by Application (2022)
Figure 24. Global Pet NSAIDs Revenue Market Share by Application in 2022
Figure 25. Pet NSAIDs Sales Market by Company in 2022 (K Units)
Figure 26. Global Pet NSAIDs Sales Market Share by Company in 2022
Figure 27. Pet NSAIDs Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Pet NSAIDs Revenue Market Share by Company in 2022
Figure 29. Global Pet NSAIDs Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Pet NSAIDs Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Pet NSAIDs Sales 2018-2023 (K Units)
Figure 32. Americas Pet NSAIDs Revenue 2018-2023 ($ Millions)
Figure 33. APAC Pet NSAIDs Sales 2018-2023 (K Units)
Figure 34. APAC Pet NSAIDs Revenue 2018-2023 ($ Millions)
Figure 35. Europe Pet NSAIDs Sales 2018-2023 (K Units)
Figure 36. Europe Pet NSAIDs Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Pet NSAIDs Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Pet NSAIDs Revenue 2018-2023 ($ Millions)
Figure 39. Americas Pet NSAIDs Sales Market Share by Country in 2022
Figure 40. Americas Pet NSAIDs Revenue Market Share by Country in 2022
Figure 41. Americas Pet NSAIDs Sales Market Share by Type (2018-2023)
Figure 42. Americas Pet NSAIDs Sales Market Share by Application (2018-2023)
Figure 43. United States Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Pet NSAIDs Sales Market Share by Region in 2022
Figure 48. APAC Pet NSAIDs Revenue Market Share by Regions in 2022
Figure 49. APAC Pet NSAIDs Sales Market Share by Type (2018-2023)
Figure 50. APAC Pet NSAIDs Sales Market Share by Application (2018-2023)
Figure 51. China Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Pet NSAIDs Sales Market Share by Country in 2022
Figure 59. Europe Pet NSAIDs Revenue Market Share by Country in 2022
Figure 60. Europe Pet NSAIDs Sales Market Share by Type (2018-2023)
Figure 61. Europe Pet NSAIDs Sales Market Share by Application (2018-2023)
Figure 62. Germany Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Pet NSAIDs Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Pet NSAIDs Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Pet NSAIDs Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Pet NSAIDs Sales Market Share by Application (2018-2023)
Figure 71. Egypt Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Pet NSAIDs Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Pet NSAIDs in 2022
Figure 77. Manufacturing Process Analysis of Pet NSAIDs
Figure 78. Industry Chain Structure of Pet NSAIDs
Figure 79. Channels of Distribution
Figure 80. Global Pet NSAIDs Sales Market Forecast by Region (2024-2029)
Figure 81. Global Pet NSAIDs Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Pet NSAIDs Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Pet NSAIDs Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Pet NSAIDs Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Pet NSAIDs Revenue Market Share Forecast by Application (2024-2029)
